Delivery Order SPE2DB20D9136-SPE2DB25FJ59Y
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $1,670.13 by the Defense Logistics Agency for the supply of YF-VAX 1 Dose Vials. This firm fixed-price delivery order, issued on July 24, 2025, carries an ultimate completion date of August 14, 2025, with no set-aside designation applied to the award. The contract represents a continuation of DMS Pharmaceutical Group's substantial role...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $27,835.50 by the Defense Logistics Agency for YF-VAX 1 dose vials. The contract is firm fixed price with no set-aside designation, reflecting the company's competitive standing in federal procurement. The delivery order is set for ultimate completion by August 15, 2025, with performance to take place at the vendor's Park Ridge, Illinois...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,670.13 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, which carries an ultimate completion date of August 25, 2025, was awarded without a set-aside designation. The delivery order represents a continuation of DMS Pharmaceutical Group's role as a critical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,113.42 by the Defense Logistics Agency (DLA) on September 2, 2025, for YF-VAX 1 dose vials. The award is a firm fixed-price delivery order with no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical procurement. Performance is scheduled for completion by September 23, 2025, at the contractor's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $13,917.75 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 20, 2025, for YF-VAX 1 dose vials. The contract carries an ultimate completion date of September 11, 2025, and was awarded without set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against an indefinite delivery contract with the Defense Logistics Agency for $3,283.80 to supply 1,056 doses of YF-VAX vaccine. The delivery order has a completion date of November 15, 2023 and was awarded on October 24, 2023. DMS Pharmaceutical Group will provide the vaccine doses from its facility located in Park Ridge, Illinois to fulfill requirements under the Defense Logistics Agency's pharmaceutical prime...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,340.26 by the Defense Logistics Agency for YF-VAX 1 dose vials. The contract was awarded on August 4, 2025, with an ultimate completion date of August 25, 2025, and carries firm fixed-price terms with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,701.30 by the Defense Logistics Agency on July 25, 2025, for the supply of YF-VAX 1 dose vials. This delivery order is issued without a set-aside designation and carries an ultimate completion date of August 15, 2025. The contract will be performed at the vendor's facility in Park Ridge, Illinois. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $54,730.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of YF-VAX 1 dose vials, with a performance period ending on June 9, 2023. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 25, 2025, for YF-VAX 1 dose vials with a ceiling value of $2,226.84. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 15, 2025, and will be performed at the vendor's Park Ridge location. The award falls under DMS Pharmaceutical...
- SPE2DB20D9136Indefinite Delivery Contract
- SPE2DB20D9136-SPE2DB25FJ59YDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,567.10 by the Defense Logistics Agency on September 3, 2025, for the supply of YF-VAX 1 Dose Vials. The contract carries an ultimate completion date of September 24, 2025, and involves no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its robust portfolio of delivery orders to the Defense Logistics Agency, providing prescription medications, biologics, vaccines, and medical consumables to Department of Defense healthcare sites. The company's federal contracting history demonstrates consistent success in competing for pharmaceutical supply contracts without set-aside designations, leveraging its status as a woman-owned small business and its established SAM.gov registration since 2001 to secure positions on major procurement vehicles supporting military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/3/25 |